Literature DB >> 23903572

Mouse gender influences brain transduction by intravascularly administered AAV9.

Casey A Maguire, Matheus Hw Crommentuijn, Dakai Mu, Eloise Hudry, Alberto Serrano-Pozo, Bradley T Hyman, Bakhos A Tannous.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23903572      PMCID： PMC3734655          DOI： 10.1038/mt.2013.95

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  15 in total

1.  Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons.

Authors:  Sandra Duque; Béatrice Joussemet; Christel Riviere; Thibaut Marais; Laurence Dubreil; Anne-Marie Douar; John Fyfe; Philippe Moullier; Marie-Anne Colle; Martine Barkats
Journal:  Mol Ther       Date:  2009-04-14       Impact factor: 11.454

2.  Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both genders.

Authors:  Astrid Pañeda; Lucia Vanrell; Itsaso Mauleon; Julien S Crettaz; Pedro Berraondo; Eric J Timmermans; Stuart G Beattie; Jaap Twisk; Sander van Deventer; Jesus Prieto; Antonio Fontanellas; Maria Sol Rodriguez-Pena; Gloria Gonzalez-Aseguinolaza
Journal:  Hum Gene Ther       Date:  2009-08       Impact factor: 5.695

3.  Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo.

Authors:  Christina A Pacak; Cathryn S Mah; Bijoy D Thattaliyath; Thomas J Conlon; Melissa A Lewis; Denise E Cloutier; Irene Zolotukhin; Alice F Tarantal; Barry J Byrne
Journal:  Circ Res       Date:  2006-07-27       Impact factor: 17.367

4.  Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8.

Authors:  Katsuya Inagaki; Sally Fuess; Theresa A Storm; Gregory A Gibson; Charles F Mctiernan; Mark A Kay; Hiroyuki Nakai
Journal:  Mol Ther       Date:  2006-05-19       Impact factor: 11.454

5.  AAV8, 9, Rh10, Rh43 vector gene transfer in the rat brain: effects of serotype, promoter and purification method.

Authors:  Ronald L Klein; Robert D Dayton; Jason B Tatom; Karen M Henderson; Phillip P Henning
Journal:  Mol Ther       Date:  2007-10-23       Impact factor: 11.454

6.  Enhancing transduction of the liver by adeno-associated viral vectors.

Authors:  A C Nathwani; M Cochrane; J McIntosh; C Y C Ng; J Zhou; J T Gray; A M Davidoff
Journal:  Gene Ther       Date:  2008-08-14       Impact factor: 5.250

7.  Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.

Authors:  Kevin D Foust; Emily Nurre; Chrystal L Montgomery; Anna Hernandez; Curtis M Chan; Brian K Kaspar
Journal:  Nat Biotechnol       Date:  2008-12-21       Impact factor: 54.908

8.  Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat.

Authors:  Lawrence T Bish; Kevin Morine; Meg M Sleeper; Julio Sanmiguel; Di Wu; Guangping Gao; James M Wilson; H Lee Sweeney
Journal:  Hum Gene Ther       Date:  2008-12       Impact factor: 5.695

9.  Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection.

Authors:  Carmela Zincarelli; Stephen Soltys; Giuseppe Rengo; Joseph E Rabinowitz
Journal:  Mol Ther       Date:  2008-04-15       Impact factor: 11.454

10.  Clades of Adeno-associated viruses are widely disseminated in human tissues.

Authors:  Guangping Gao; Luk H Vandenberghe; Mauricio R Alvira; You Lu; Roberto Calcedo; Xiangyang Zhou; James M Wilson
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103
View more
  17 in total

1.  Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain.

Authors:  Dongfen Yuan; Yuling Zhao; William A Banks; Kristin M Bullock; Matthew Haney; Elena Batrakova; Alexander V Kabanov
Journal:  Biomaterials       Date:  2017-07-10       Impact factor: 12.479

2.  Trafficking of adeno-associated virus vectors across a model of the blood-brain barrier; a comparative study of transcytosis and transduction using primary human brain endothelial cells.

Authors:  Steven F Merkel; Allison M Andrews; Evan M Lutton; Dakai Mu; Eloise Hudry; Bradley T Hyman; Casey A Maguire; Servio H Ramirez
Journal:  J Neurochem       Date:  2016-12-15       Impact factor: 5.372

3.  Comparative efficacy and safety of multiple routes of direct CNS administration of adeno-associated virus gene transfer vector serotype rh.10 expressing the human arylsulfatase A cDNA to nonhuman primates.

Authors:  Jonathan B Rosenberg; Dolan Sondhi; David G Rubin; Sébastien Monette; Alvin Chen; Sara Cram; Bishnu P De; Stephen M Kaminsky; Caroline Sevin; Patrick Aubourg; Ronald G Crystal
Journal:  Hum Gene Ther Clin Dev       Date:  2014-08-21       Impact factor: 5.032

4.  Long-term correction of hemophilia B using adenoviral delivery of CRISPR/Cas9.

Authors:  Calvin J Stephens; Elvin J Lauron; Elena Kashentseva; Zhi Hong Lu; Wayne M Yokoyama; David T Curiel
Journal:  J Control Release       Date:  2019-02-13       Impact factor: 9.776

5.  Systemic AAV9 gene transfer in adult GM1 gangliosidosis mice reduces lysosomal storage in CNS and extends lifespan.

Authors:  Cara M Weismann; Jennifer Ferreira; Allison M Keeler; Qin Su; Linghua Qui; Scott A Shaffer; Zuoshang Xu; Guangping Gao; Miguel Sena-Esteves
Journal:  Hum Mol Genet       Date:  2015-05-10       Impact factor: 6.150

Review 6.  Lysosomal storage disease: gene therapy on both sides of the blood-brain barrier.

Authors:  Elena L Aronovich; Perry B Hackett
Journal:  Mol Genet Metab       Date:  2014-10-07       Impact factor: 4.797

7.  Adeno-associated virus mediated expression of monoclonal antibody MR191 protects mice against Marburg virus and provides long-term expression in sheep.

Authors:  Amira D Rghei; Laura P van Lieshout; Wenguang Cao; Shihua He; Kevin Tierney; Jordyn A Lopes; Nicole Zielinska; Enzo M Baracuhy; Elena S B Campbell; Jessica A Minott; Matthew M Guilleman; Pamela C Hasson; Brad Thompson; Khalil Karimi; Byram W Bridle; Leonardo Susta; Xiangguo Qiu; Logan Banadyga; Sarah K Wootton
Journal:  Gene Ther       Date:  2022-09-01       Impact factor: 4.184

8.  Gene therapy for Alzheimer's disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation.

Authors:  Ana Griciuc; Anthony N Federico; Jeyashree Natasan; Angela M Forte; Danielle McGinty; Huong Nguyen; Adrienn Volak; Stanley LeRoy; Sheetal Gandhi; Eli P Lerner; Eloise Hudry; Rudolph E Tanzi; Casey A Maguire
Journal:  Hum Mol Genet       Date:  2020-10-10       Impact factor: 6.150

9.  Naturally enveloped AAV vectors for shielding neutralizing antibodies and robust gene delivery in vivo.

Authors:  Bence György; Zachary Fitzpatrick; Matheus H W Crommentuijn; Dakai Mu; Casey A Maguire
Journal:  Biomaterials       Date:  2014-06-07       Impact factor: 12.479

10.  Intracranial AAV-sTRAIL combined with lanatoside C prolongs survival in an orthotopic xenograft mouse model of invasive glioblastoma.

Authors:  Matheus H W Crommentuijn; Casey A Maguire; Johanna M Niers; W Peter Vandertop; Christian E Badr; Thomas Würdinger; Bakhos A Tannous
Journal:  Mol Oncol       Date:  2015-12-11       Impact factor: 6.603
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.